PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.31%
Negative revenue growth while ADI stands at 5.75%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
2.08%
Gross profit growth under 50% of ADI's 5.99%. Michael Burry would be concerned about a severe competitive disadvantage.
24.74%
EBIT growth above 1.5x ADI's 8.81%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
24.74%
Operating income growth above 1.5x ADI's 8.81%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
587.55%
Net income growth above 1.5x ADI's 9.26%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
558.82%
EPS growth above 1.5x ADI's 7.69%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
568.75%
Diluted EPS growth above 1.5x ADI's 8.33%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.89%
Share count expansion well above ADI's 0.60%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.76%
Diluted share count expanding well above ADI's 0.60%. Michael Burry would fear significant dilution to existing owners' stakes.
-3.88%
Dividend reduction while ADI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-9.44%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-26.97%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
41.78%
10Y revenue/share CAGR under 50% of ADI's 145.60%. Michael Burry would suspect a lasting competitive disadvantage.
2.59%
5Y revenue/share CAGR under 50% of ADI's 55.00%. Michael Burry would suspect a significant competitive gap or product weakness.
-7.06%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
37.89%
Below 50% of ADI's 397.22%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
31.84%
Positive 3Y OCF/share CAGR while ADI is negative. John Neff might see a big short-term edge in operational efficiency.
2355.49%
10Y net income/share CAGR of 2355.49% while ADI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
2232.04%
5Y net income/share CAGR above 1.5x ADI's 546.89%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
780.74%
Positive short-term CAGR while ADI is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
146.09%
5Y equity/share CAGR above 1.5x ADI's 93.01%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
111.23%
Positive short-term equity growth while ADI is negative. John Neff sees a strong advantage in near-term net worth buildup.
84.04%
Dividend/share CAGR of 84.04% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
8.03%
Dividend/share CAGR of 8.03% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
39.18%
3Y dividend/share CAGR of 39.18% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-0.17%
Firm’s AR is declining while ADI shows 6.47%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
2.85%
Inventory growth well above ADI's 1.88%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
28.62%
Asset growth above 1.5x ADI's 3.94%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
40.37%
BV/share growth above 1.5x ADI's 5.65%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-5.41%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-1.79%
Our R&D shrinks while ADI invests at 4.39%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-11.65%
We cut SG&A while ADI invests at 4.26%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.